570 Results (Page 20 of 23)
Germany Markets Research Reports
Germany Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Germany dermatology drugs market will reach a value of $1,240 Mn from $622 Mn in 2022, growing at a CAGR of 9% during 2022-2030. The market is primarily dominated by local players such as Merck KGaA, Stada Arzneimittel, and Beiersdorf. The market is driven by innovation and development, better health insurance, and strict regulations. The dermatology drug market in Germany is segmented by drug class, drug type, prescription mode, indication, route of administration, end user and distribution channel.
Germany Healthcare Insurance Market Analysis
German's healthcare insurance market is projected to grow from $74.16 Bn in 2022 to $116.43 Bn by 2030, registering a CAGR of 5.8% during the forecast period of 2022-2030. The main factors driving the growth would be the ageing population, technological advancements, rising healthcare costs and competition among insurers. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include HanseMerkur, Arag, Hallesche, SDK, uniVersa and Alte Oldenburger.
Germany Oncology Drugs Market Analysis
The oncology drugs market in Germany is a significant and growing market, as cancer is a major public health issue. According to a report published by Insights10, the oncology drugs market in Germany was valued at $7.19 Bn in 2022 and is expected to reach $15.19 Bn by 2030, at a CAGR of 9.8% during the forecast period. The market is highly competitive, with a large number of players like Baxter, Daiichi Sankyo Europe, Novartis etc offering a wide range of cancer treatment options.
Germany Dialysis Market Analysis
Germany's dialysis market is projected to grow from $1.395 Bn in 2022 to $2.581 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-2030. One of the main reasons propelling market growth in Europe is the expanding elderly population. In 2020, 91% of the dialysis market in Europe was accounted for by the hemodialysis segment. Due to its increased dialysis efficacy, patients choose hemodialysis (HD). Additionally, the emergence of less complicated hemodialysis machines has made home hemodialysis easy. With the right training and assistance from a friend or family member, one may be able to perform hemodialysis at home.
Germany Physiotherapy Market Analysis
Insights10 report on Germany physiotherapy market analysis projects the growth of the physiotherapy market by $1.94 Bn in 2022 with a CAGR of 4.05% and is expected to reach $2.67 Bn in 2030. As physiotherapy concentrates more on rehabilitative and preventive treatments, the prevalence of cardiovascular and neurological disorders in geriatric populations are the main market drivers in the Germany physiotherapy market. The physiotherapy market is segmented by equipment, applications, and by end-users in Germany. Some leading companies in the physiotherapy market are BTL Industries, Performance Health, ITO Co. Ltd., and Enraf-Nonius B.V.
Germany Dental Care Market Analysis
This report presents a strategic analysis of the Germany dental care market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Germany Dental Care Market, offering unmatched value, accuracy and expert insights.
Germany ECG Equipments Market Analysis
The German ECG Equipment Market is expected to witness growth from $326 Mn in 2022 to $500 Mn in 2030 with a CAGR of 5.50% for the forecasted year 2022-2030. The ageing populace in Germany is increasing the demand for medical services, including ECG equipment. There is a growing need for ECG devices for diagnosis and monitoring as the population ages and the prevalence of heart disease and other cardiovascular conditions rises. The market is segmented by product type and by the end user. Some key players in this market include Rein Medical GmbH, KLS Martin, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
Germany 3D Printing Medical Devices Market Analysis
Germany's 3D printing medical devices market size was valued at $109 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.5% from 2022 to 2030 and will reach $321 Mn in 2030. The market is segmented by component, application, technology, and end user. The Germany 3D printing medical devices market will grow as 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include SLM Solutions Group AG, EOS GmbH, Concept Laser GmbH, Materialise NV, Stratasys Ltd, 3D Systems Corporation, and others.
Germany Depression Therapeutics Market Analysis
The German depression therapeutics market is expected to witness growth from $370 Mn in 2022 to $483 Mn in 2030 with a CAGR of 3.4% for the forecasted year 2022-2030. The growing awareness of depression and the rising technological advancements like telemedicine and digital therapeutics are the major market drivers. The German depression therapeutics market is segmented by drug type, therapies, indication, and by end users. ix Therapeutics, Denk Pharma, and AstraZeneca are the major players in the German depression therapeutics market.
Germany Biomaterials in Healthcare Market Analysis
The Germany Biomaterials Healthcare Market is expected to witness growth from $5.71 Bn in 2022 to $13.56 Bn in 2030 with a CAGR of 11.40% for the forecasted year 2022-2030. A growing need for regenerative medicine and an ageing populace are the main factors driving Germany's biomaterials healthcare market. The market is segmented by type and by application. Some key players in this market include Evonik Industries, Merck KGaA, Matricel, BASF SE, Covestro AG and Celanese.
Germany Diabetes Devices Market Analysis
The Germany Diabetes Devices Market is expected to witness growth from $832 Mn in 2022 to $1267 Mn in 2030 with a CAGR of 5.40% for the forecasted year 2022-2030. The demand for diabetes devices is being driven by the high and rising incidence of diabetes in Germany. The market is segmented by type and by the end user. Some key players in this market include Rein Medical GmbH, KLS Martin, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Germany Cardiac Surgery Instruments Market Analysis
The Germany Cardiac Surgery Instruments Market is expected to witness growth from $76 Mn in 2022 to $110 Mn in 2030 with a CAGR of 4.80% for the forecasted year 2022-2030. In Germany, coronary heart disease, heart failure, and atrial fibrillation are among the leading causes of morbidity and death. The demand for cardiac surgery equipment is anticipated to increase as these illnesses become more common in the German healthcare market. The market is segmented by type, application and by end user. Some key players in this market include KLS Martin, Aesculap AG, RZ Medizintechnik GmbH, LivaNova, B. Braun, Medline Industries and STILLE.
Germany Cardiovascular Diseases Therapeutics Market Analysis
Germany's cardiovascular disease therapeutics market is expected to witness growth from $5.95 Bn in 2022 to $9.08 Bn in 2030 with a CAGR of 5.42% for the year 2022-2030. Technological advancements and supportive government policies in terms of cardiovascular diseases in Germany are responsible for the growth of the market. The Germany cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Waypharm, Cordes Pharma, and Pfizer are the major players in the Germany cardiovascular disease therapeutics market.
Germany Healthcare Claims Management Market Analysis
The German healthcare claims management market is projected to grow from $977.22 Mn in 2022 to $4671.55 Mn by 2030, registering a CAGR of 21.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare expenditure, regulatory reforms, technological advancements and growing demand for outsourcing. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include AOK Systems, CompuGroup Medical, McKesson, Cognizant and Optum.
Germany ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Germany's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $1.08 Bn in 2022 to $1.68 Bn in 2030 with a CAGR of 5.7% for the year 2022-30. The major market drivers include rising awareness of the disorder and the increasing supply of ADHD drugs which include both stimulants and non-stimulants. The Germany ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the major competitors in the market are Adragos Pharma, Hermes Arzneimittel, and Shire.
Germany Oncology Clinical Trials Market Analysis
Germany's oncology clinical trials market is projected to grow from $463 Mn in 2022 to $619.2 Mn by 2030, registering a CAGR of 3.7% during the forecast period of 2022-30. The market will be driven by the strong healthcare infrastructure, focus on personalized medicine, and experienced workforce. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Roche Holding AG, Bayer AG & BioNTech SE.
Germany Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Germany Liver Disease Therapeutics market will reach a value of $1148 Mn from $845 Mn in 2022, growing at a CAGR of 3.9% during 2022-2030. Liver Disease Therapeutics in Germany is dominated by a few domestic pharmaceutical companies such as Boehringer Ingelheim, Bayer, and BioNTech. The Liver Disease Therapeutics market in Germany is segmented into different types of disease and different therapy types. Some of the major factors affecting the German Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Germany Diabetes Drugs Market Analysis
The Germany diabetes drugs market size was valued at $2.26 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.3% from 2022 to 2030 and will reach $3.16 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Germany diabetes drug market will grow because there is a growing focus on preventive measures to reduce the risk of developing diabetes, including lifestyle changes, which is also driving the demand for diabetes management products and services. The key market players are Boehringer Ingelheim, Sanofi, Boehringer Ingelheim, Eli Lilly and Company and others.
Germany Alexipharmic Drugs Market Analysis
Germany's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 2.90% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The Germany Alexipharmic Drugs market will grow because of growing awareness in Germany about the risks of poisoning and the importance of having quick access to antidotes in case of an emergency. The key market players are Merck KGaA (DEU), CSL Behring (DEU), Grifols Deutschland (DEU), Wockhardt GmbH (DEU), B. Braun Melsungen AG (DEU), and others.
Germany Connected Healthcare Market Analysis
The Germany-connected healthcare market is projected to grow from $2.43 Bn in 2022 to $16.03 Bn by 2030, registering a CAGR of 26.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, strong healthcare infrastructure, research and development infrastructure and government support. The market is segmented by type, function and by application. Some of the major players include Siemens Healthineers, Fresenius Medical Care, CompuGroup Medical, Telekom Healthcare Solutions, Philips Healthcare, IBM, Medtronic, Apple and Honeywell.
Germany Artificial Intelligence (AI) in Medical Imaging Market Analysis
The Germany Artificial Intelligence (AI) in Medical Imaging market size was valued at $55 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 33.6% from 2022 to 2030 and will reach $557 Mn. The market is segmented by AI technology, solution, modality, application, and end User. The Germany Artificial Intelligence (AI) in the Medical Imaging market will grow due to advances in AI and machine learning algorithms that are making it possible to develop more accurate and efficient medical imaging software. Some of the key players in this market are Siemens Healthineers, Philips Healthcare, Agfa-Gevaert Group, Canon Medical Systems, Fujifilm, and others.
Germany Neurology Clinical Trials Market Analysis
The Germany Neurology Clinical Trials market is projected to grow from $191.4 Mn in 2022 to $256 Mn by 2030, registering a CAGR of 3.7% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, multiple sclerosis, and epilepsy and regulatory frameworks that encourage clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer & Bayer.
Germany Teleradiology Market Analysis
The Germany Teleradiology market size was valued at $87 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.9% from 2022 to 2030 and will reach $ 185 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Germany teleradiology market will grow due to Increasing demand for remote radiology services. The key market players are Radiology Consultants Associated (RCA), NightHawk Radiology Services, Calgary Scientific, and others.
Germany Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the German infectious disease therapeutics market will reach a value of $5.37 Bn from $4.39 Bn in 2022, growing at a CAGR of 2.6% during 2022-2030. Infectious Disease Therapeutics in Germany is dominated by a few domestic pharmaceutical companies such as BioNTech, Evotec and InfectoPharm. The Infectious Disease Therapeutics market in Germany is segmented into different therapeutic areas and different diseases type. The major factors affecting the German infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious disease treatment in various areas of Germany.
Germany Clinical Diagnostics Market Analysis
Germany's clinical diagnostic market was valued at $2.52 Bn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022-30 and will reach $3.50 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Merck and others.
